about
A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicityIsolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolidesSynthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance proteinMechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studiesApoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrinFLT3: ITDoes matter in leukemia.Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1Reversal of MDR by verapamil analogues.Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.The Roles of MicroRNAs in Breast CancerPK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanismABCG2 expression, function, and promoter methylation in human multiple myelomaGene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.Assessment of drug resistance in acute myeloid leukemia.DualChip microarray as a new tool in cancer research.p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines.Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo.Targeting the leukemic stem cell: the Holy Grail of leukemia therapyStem cell differentiation by functionalized micro- and nanostructured surfaces.11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia.Multidrug resistance in the chronic lymphoproliferative disorders.Recurrent growth factor starvation promotes drug resistance in human leukaemic cellsCD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.The frequency and clinical relevance of multidrug resistance protein expression in patients with lymphoma.Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.In Silico Prediction of Mechanism of Action for Cancer Therapeutics.Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines.HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells.Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.mRNA overexpression of BAALC: A novel prognostic factor for pediatric acute lymphoblastic leukemia.
P2860
Q28477095-F0E9B0F2-E415-4C1C-85B6-81BCDBFDA191Q30438086-F06A79C4-3516-4BDA-955E-958C2A0D7354Q30439828-18C9F83F-3DF3-4096-801F-5510EEA234FAQ30718056-23F8032C-8AFA-4716-B543-12754377E5D3Q33823577-DB9C3A87-B88B-4CD3-A337-BC95DCF17039Q33837236-04C0A0C6-6693-444F-937B-8628D153BD5BQ33947942-AE9E7EFF-840A-4F07-BC3B-3A31D431FF45Q35217399-5FCFF569-50AD-47A7-AF28-55AC25919878Q35640339-E6300753-2143-42C8-82F4-E03CF3957476Q35668684-72F1BE80-3D51-4790-BF15-400FF64EFA49Q35771377-4058C478-0D46-4606-97BD-22F8FF65E747Q35818407-F72C2708-A844-4208-BBC5-B0F6DF00CACDQ35847659-4AE7FDA6-2E5E-490D-BE10-F086C9FC62E1Q35848835-56506452-DABB-4428-BD41-67593A83D1CAQ35848938-65BAEF97-1270-443E-994E-D2E8957F67E3Q35878296-1386BFD3-CFCB-4050-A9F4-8C267BCC7092Q36481097-7F1B5ECD-222B-468A-AF6D-C985AEC141D8Q36568079-2F645EC6-C5F0-4520-B61D-3F19437532A4Q36609738-360D1F91-23B0-49C9-AFE1-D1BB8699185BQ36788463-4539923B-3E34-4ACA-82C3-EA6FA0F36E6FQ36845030-7128616B-F046-4FFB-8B3C-D87B62DD8AE6Q37272565-E3A5BA5B-60FC-405D-8F08-CECAB158628DQ37288974-510378A4-B749-41E7-91F9-E3A73CB3A344Q37323423-30CD713C-976F-4551-A00F-9BDF7756FB12Q37396799-3409BF53-8C03-4F82-A411-A55B37E50157Q37549450-A39472EA-928B-4692-9A44-86B98C40690AQ37771031-C462B987-5BEF-4200-9904-8DA573D1A2FCQ38281768-E980AAA2-02AB-47B4-BDE9-6CB4B70F538BQ38289911-C390B6A0-BC62-40B1-8DEB-F78D3AD70927Q38354761-FF91FCF2-C09D-4DF1-9508-3E73559D4A1EQ38756867-47F5540E-6F03-4EFE-B167-6463DC0C032CQ38795351-97750A1A-2E57-4D0F-8F50-753AB59E43CEQ39375647-DF1120B1-A094-4698-AD77-F53A5D821EF3Q39599792-76722E58-76E4-46DD-9C51-D93A3C1390C9Q39978610-DBECF58D-9658-4AD6-B4CE-72554C342F6EQ40039548-680C01AD-046E-4E55-A37B-3CE4458E2300Q40154931-C8BA5D8E-F7F9-4C4D-9DB2-540CCE973B03Q40239521-DA4C53CA-AFFE-4213-8061-639008483708Q40623805-B8AA5AF7-09F9-4886-A676-544FB497E607Q42177488-DB46CC9D-D0C7-426E-A0F3-5B0634DCB6AD
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Novel mechanisms of drug resistance in leukemia.
@ast
Novel mechanisms of drug resistance in leukemia.
@en
type
label
Novel mechanisms of drug resistance in leukemia.
@ast
Novel mechanisms of drug resistance in leukemia.
@en
prefLabel
Novel mechanisms of drug resistance in leukemia.
@ast
Novel mechanisms of drug resistance in leukemia.
@en
P356
P1433
P1476
Novel mechanisms of drug resistance in leukemia.
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2401694
P577
2000-03-01T00:00:00Z
P5875
P6179
1014028281